Moberg Pharma has appointed Dr. Cindy Wong as Chief Medical Officer. Dr Wong brings extensive international experience in clinical development and registration of new products in several treatment areas including dermatology. She has held positions as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH and Chief Medical Officer at Q-Med/Galderma, as well as senior positions at regulatory authorities in both Sweden and Australia. Dr. Wong is board certified in internal medicine and clinical immunology.

“We look forward to welcoming Cindy to Moberg Pharma. She will be joining the company in a highly exciting stage as we recently completed phase 3-trials for MOB-015, where she will be adding valuable experience from the development, registration and commercialization of novel treatments”, says Anna Ljung, CEO Moberg Pharma.